AzTrials
AzTrials

Hiatal HerniaNCT07902895

Intrathoracic Sleeve Migration (Sliding Hiatal Hernia) One Year or More After Laparoscopic Sleeve Gastrectomy

An observational study of Hiatal Hernia and Gastroesophageal Reflux Disease, run by Kasr El Aini Hospital at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Sleeve gastrectomy is the most commonly performed metabolic bariatric operation. After the operation, the upper part of the gastric sleeve can slide up through the opening in the diaphragm into the chest. This is called intrathoracic sleeve migration and is a form of sliding hiatal hernia. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Laparoscopic sleeve gastrectomy and CT of the thorax and abdomen with oral water-soluble contrast
How many people
61 participants
Where
1 siteEgypt
Study dates
1 Apr 2026to 30 Sep 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adults with obesity who underwent primary laparoscopic sleeve gastrectomy in the Department of General Surgery, Cairo University Hospitals (Kasr Al-Ainy), between July 2024 and August 2025, identified from the department's records and assessed 12 months or more after surgery.

Who may be able to join

  • Adults (18 years or older) with a preoperative body mass index above 35 kg/m²
  • Primary laparoscopic sleeve gastrectomy between July 2024 and August 2025
  • 12 months or more after surgery

Who cannot join

  • Roux-en-Y gastric bypass or one-anastomosis (mini) gastric bypass
  • Revisional bariatric surgery
  • Hiatal hernia or gastro-oesophageal reflux disease diagnosed before surgery
  • Hiatal hernia found at operation
  • Hiatal dissection, hiatal hernia repair or sleeve fixation performed at the index operation

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Kasr El Aini Hospital, Cairo University

    Cairo

Other trials in Egypt

About this study

Official title: Incidence of Intra-thoracic Sleeve Migration (Sliding Hiatus Hernia) One Year Post Laparoscopic Sleeve Gastrectomy

Sleeve gastrectomy is the most commonly performed metabolic bariatric operation. After the operation, the upper part of the gastric sleeve can slide up through the opening in the diaphragm into the chest. This is called intrathoracic sleeve migration and is a form of sliding hiatal hernia. It may cause new reflux symptoms such as heartburn, regurgitation and vomiting, and may lead to further surgery. How often it happens is uncertain, because studies have used different definitions and tests.

This single-centre observational study included adults who had a laparoscopic sleeve gastrectomy at Cairo University Hospitals between July 2024 and August 2025 and were at least one year after surgery. Each patient had a CT scan of the chest and abdomen with oral contrast to look for migration of the sleeve above the diaphragm, and completed the GERD-Q reflux questionnaire. The study measured how often intrathoracic sleeve migration occurs one year or more after sleeve gastrectomy, whether it is associated with new (de novo) reflux disease, and which patient factors may be associated with it.

Read the detailed description

Background

Laparoscopic sleeve gastrectomy (LSG) is associated with de novo gastro-oesophageal reflux disease (GERD). One proposed mechanism is intrathoracic sleeve migration (ITSM): upward migration of the proximal sleeve, with its staple line, through the oesophageal hiatus after an operation in which the sleeve was entirely intra-abdominal. Reported rates range from about 5% to 45%, largely because of differing diagnostic definitions and imaging methods.

Design and setting

Single-centre observational cohort study in the Department of General Surgery, Cairo University Hospitals (Kasr Al-Ainy), Cairo, Egypt. Patients who underwent primary LSG between July 2024 and August 2025 were identified from the department's records and invited to a single study visit 12 months or more after surgery. Study visits (CT and GERD-Q) took place between April 2026 and September 2026. The protocol was approved by the Research Ethics Committee, Faculty of Medicine, Cairo University (code MS-620-2025) on 11 March 2026, before the first study visit. The study forms the basis of an MSc thesis in General Surgery (candidate: Dr. Dalia Moharam Hussein Mustafa).

Data collection

From the medical records: age, sex, preoperative body mass index (BMI), preoperative GERD status and operative details, to confirm that no hiatal hernia was found at operation and that no hiatal dissection, hiatal repair or sleeve fixation was performed. At the study visit: symptom history (heartburn, regurgitation, vomiting and others) and time of symptom onset after surgery, the GERD-Q questionnaire, and height, weight and BMI.

Imaging

CT of the thorax and abdomen (to the pubis) after oral water-soluble contrast, with 5 mm slices. Images were reconstructed and analysed by a single operator. The level of the oesophageal hiatus was identified along the staple line, and migration of the proximal end of the staple line above the hiatus was measured in millimetres.

Definitions

  • ITSM: proximal end of the sleeve staple line above the level of the oesophageal hiatus on CT.
  • GERD: GERD-Q score of 8 or more.
  • Because patients with GERD or hiatal hernia before surgery were excluded, postoperative GERD is regarded as de novo.

Statistical analysis

SPSS version 26. Normality is assessed with the Shapiro-Wilk test and histograms. Continuous data are summarised as mean and standard deviation or median and interquartile range, and compared between patients with and without ITSM using the Student t-test or the Mann-Whitney U test (paired t-test or Wilcoxon signed-rank test for paired observations). Categorical data are compared with the chi-square or Fisher exact test. A two-sided P value below 0.05 is considered significant.

Being tested
Laparoscopic sleeve gastrectomy, CT of the thorax and abdomen with oral water-soluble contrast
Keywords
Laparoscopic sleeve gastrectomy, Intrathoracic sleeve migration, Sliding hiatal hernia, De novo GERD, GERD-Q, Computed tomography, Metabolic bariatric surgery
Medical subject headings
Hernia, Hiatal, Gastroesophageal Reflux, Obesity, Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laparoscopic sleeve gastrectomyProcedure or surgery

    Primary laparoscopic sleeve gastrectomy performed as part of routine care before enrolment. This is the exposure of interest; it was not assigned by the study.

  • CT of the thorax and abdomen with oral water-soluble contrastDiagnostic test

    Single CT examination at the study visit (5 mm slices) to detect and measure migration of the proximal sleeve staple line above the oesophageal hiatus.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of intrathoracic sleeve migration (ITSM)

    Proportion of patients with ITSM on CT of the thorax and abdomen with oral water-soluble contrast, defined as the proximal end of the gastric sleeve staple line lying above the level of the oesophageal hiatus. The extent of migration above the hiatus is measured in millimetres.

    Measured: At a single study visit, 12 months or more after laparoscopic sleeve gastrectomy

Secondary outcomes (2)
  1. Association between ITSM and de novo gastro-oesophageal reflux disease (GERD)

    Proportion of patients with GERD, defined as a GERD-Q score of 8 or more (score range 0 to 18; higher scores indicate a higher likelihood of GERD), compared between patients with and without ITSM. Patients with GERD before surgery were excluded, so postoperative GERD is regarded as de novo. Reflux-related symptoms (heartburn, regurgitation, vomiting) and the time of symptom onset after surgery are also compared between the two groups.

    Measured: At a single study visit, 12 months or more after laparoscopic sleeve gastrectomy

  2. Patient factors associated with ITSM

    Age (years), sex, preoperative body mass index (kg/m²) and BMI reduction (preoperative minus postoperative BMI, kg/m²) compared between patients with and without ITSM.

    Measured: Preoperative (from medical records) and at a single study visit, 12 months or more after laparoscopic sleeve gastrectomy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2026
  2. Study start1 Apr 2026
  3. Primary completion30 Sep 2026
  4. Study completion30 Sep 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
61 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07902895
Sponsor's protocol ID
MS-620-2025-ITSM
Status last verified
Oct 2026
First submitted
21 Oct 2026
Last updated
29 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared; aggregate results will be reported in the publication.

Publications

  • Saber AA, Shoar S, Khoursheed M. Intra-thoracic Sleeve Migration (ITSM): an Underreported Phenomenon After Laparoscopic Sleeve Gastrectomy. Obes Surg. 2017 Aug;27(8):1917-1923. doi: 10.1007/s11695-017-2589-6.

    PubMed 28233265
  • Sarhan MD, Aboueisha HA, Fathy E, AbdelSalam MN, Abdelsalam A. Intra-thoracic Gastric Pouch Migration Following Laparoscopic Sleeve Gastrectomy - Short Term Study. Surg Gastroenterol Oncol. 2024;29(2 Suppl):S24-S29.

Questions about this trial

What is this clinical trial studying?

An observational study of Hiatal Hernia and Gastroesophageal Reflux Disease, run by Kasr El Aini Hospital at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of intrathoracic sleeve migration (ITSM) (time frame: At a single study visit, 12 months or more after laparoscopic sleeve gastrectomy). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07902895, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in